Australian company Starpharma (ASX:SPL) has announced it will present positive interim data from the trial of its DEP irinotecan at a key international oncology conference in October in the US. …
Investors boost Starpharma in response to interim data from clinical trial
September 13, 2023 Australian Biotech
Latest Video
New Stories
-
US FDA grants conditional approval to the brand name of Dimerix's DMX-200
September 25, 2023 - - Australian Biotech -
Budget outcome confirms double-digit growth for pharmaceutical spend
September 25, 2023 - - Latest News -
These major processes related to public health programs can not continue in this way
September 25, 2023 - - Latest News -
Hospital pharmacy launches new professional recognition program
September 25, 2023 - - Latest News -
The 'Week in Review' Podcast - 22 September
September 22, 2023 - - Podcast -
National and Labour commit to addressing Pharmac's fiscal 'cliff'
September 22, 2023 - - Latest News -
Moderna launches 'Welcome to the mRNAge' brand campaign
September 22, 2023 - - Latest News